Fexicrade 400 tablet - Astemax BiotechFexicrade 400 tablet - Astemax Biotech

Fexicrade 400 tablet

Introduction

Fexicarde 400 Tablet is a brand from Essendon Formulations, a division of Astemax Biotech, containing Rifaximin 400 mg as the active ingredient.

Key Ingredient

Rifaximin 400 mg is a non-absorbable rifamycin antibiotic that targets gut bacteria locally, minimizing systemic side effects while effectively reducing ammonia-producing microbes and pathogens in the intestines.

Health Benefits

It manages hepatic encephalopathy in liver cirrhosis by lowering ammonia levels to alleviate confusion, tremors, and cognitive issues, while also treating traveler’s diarrhea and IBS-D by halting bacterial growth. Long-term use prevents HE recurrence and improves gut health without broad microbiome disruption.

Typically 400 mg (1 tablet) twice or three times daily, with or without food, for 3 days in diarrhea or longer (up to weeks) for encephalopathy; follow physician guidance precisely.

Usage Precautions

May cause harmless urine discoloration, nausea, or headache; discontinue if severe diarrhea develops. Avoid in rifamycin allergies or with strong CYP3A4 inducers; monitor liver function regularly

Get a Quote
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors